The Discounted Cash Flow (DCF) valuation of Biostar Pharmaceuticals Inc (BSPM) is (64.47) USD. With the latest stock price at 0.00 USD, the upside of Biostar Pharmaceuticals Inc based on DCF is -64471312.1%.
Based on the latest price of 0.00 USD and our DCF valuation, Biostar Pharmaceuticals Inc (BSPM) is a sell. selling BSPM stocks now will result in a potential gain of 64471312.1%.
Note: valuation result may not be accurate due to the low predictability of business.
| Range | Selected | |
| WACC / Discount Rate | 3.3% - 3.3% | 3.3% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | (277.44) - (37.66) | (64.47) |
| Upside | -277438471.2% - -37657845.2% | -64471312.1% |